| Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests (NCT05457543) | Group K Diagnostics Inc. | 2022-06-30 |
| Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel (NCT05308628) | RenJi Hospital | 2022-04-30 |
| Different Doses of ZED1227 vs. Placebo in NAFLD (NCT05305599) | Dr. Falk Pharma GmbH | 2022-04-19 |
| The Visceral Adiposity Measurement and Observation Study (NCT05383456) | Theratechnologies | 2022-04-18 |
| Efficacy of Simvastatin in Alcoholic Liver Fibrosis (NCT04971577) | Anna Cruceta | 2022-02-22 |
| Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR. (NCT05239260) | Medical University of Vienna | 2022-02-01 |
| Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch (NCT05224037) | Federal State Budgetary Scientific Institution | 2022-01-21 |
| Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics (NCT05490888) | PharmaIN | 2022-01-03 |
| 18F-FAPI PET in the Diagnosis of Liver Fibrosis (NCT05262647) | The Affiliated Hospital of Qingdao University | 2021-12-12 |
| Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 (NCT05180162) | Thomas Hope | 2021-12-09 |
| Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis (NCT06308757) | University of Bologna | 2021-09-29 |
| Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors (NCT06244550) | Taipei City Hospital | 2021-09-22 |
| Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation (NCT05168982) | Chinese University of Hong Kong | 2021-08-01 |
| Study in Healthy Adults Evaluating PF-07202954 (NCT04857437) | Pfizer | 2021-05-13 |
| Bariatric Endoscopy and NAFLD (NCT04895943) | University Hospital Ostrava | 2021-04-29 |
| Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination (NCT04747457) | Echosens | 2021-04-06 |
| Effect of Imatinib in Advance Liver Fibrosis Patients (NCT05224128) | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | 2021-02-20 |
| Bariatric Endoscopy and NAFLD (NCT04669470) | University of Ostrava | 2020-10-01 |
| 68Ga-FAPI PET/CT in Liver Fibrosis Patients (NCT04533828) | First Affiliated Hospital of Fujian Medical University | 2020-09-01 |
| Serum Regucalcin Level and Chronic Hepatitis B (NCT05435599) | Konya Meram State Hospital | 2020-08-01 |
| Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis (NCT04605939) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2020-07-01 |
| Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis (NCT04429100) | Chinese University of Hong Kong | 2020-03-01 |
| A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients (NCT02289300) | A2 Healthcare Taiwan Corporation | 2020-01-01 |
| Three-Dimensional T1rho Using Spiral Fast Spin Echo (NCT05154656) | Chinese University of Hong Kong | 2020-01-01 |
| Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study) (NCT04146636) | University Hospital, Angers | 2019-12-09 |
| Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis (NCT03957629) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-11-06 |
| Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients (NCT03872024) | Echosens | 2019-09-19 |
| T1rho Imaging of Liver in Presence of Iron (NCT05154643) | Chinese University of Hong Kong | 2019-08-01 |
| Pirfenidone and Advanced Liver Fibrosis. (NCT04099407) | Grupo Mexicano para el Estudios de las Enfermedades Hepaticas | 2019-08-01 |
| MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool (NCT04168619) | The University of Hong Kong | 2019-06-10 |
| Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave Elastography (NCT03896607) | HaEmek Medical Center, Israel | 2019-03-30 |
| Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota (NCT03863730) | Odense University Hospital | 2019-03-01 |
| Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis (NCT03920605) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-02-01 |
| Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis (NCT03919565) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-02-01 |
| The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis (NCT03957070) | Sonic Incytes | 2019-02-01 |
| NAFLD and Liver Fibrosis in Obese Adolescents (NCT04561804) | Tel-Aviv Sourasky Medical Center | 2018-12-01 |
| Early Detection of Advanced Fatty Liver Disease (NCT03608748) | HaEmek Medical Center, Israel | 2018-11-01 |
| Functional MRI to Determine Severity of Cirrhosis (NCT03623360) | University of Leeds | 2018-09-01 |
| Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents (NCT03908294) | Johann Wolfgang Goethe University Hospital | 2018-08-13 |
| A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis (NCT03486899) | Bristol-Myers Squibb | 2018-06-19 |
| A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis (NCT03486912) | Bristol-Myers Squibb | 2018-06-12 |
| Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients (NCT03539757) | Children's Hospital Medical Center, Cincinnati | 2018-05-09 |
| Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo (NCT03479125) | Conatus Pharmaceuticals Inc. | 2018-02-27 |
| A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C (NCT03420768) | Bristol-Myers Squibb | 2018-02-14 |
| A Study of Experimental Medication BMS-986036 Given to Healthy Participants (NCT03445208) | Bristol-Myers Squibb | 2018-02-14 |
| A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers (NCT03568578) | Peking University First Hospital | 2018-01-28 |
| ObeSity Related Colorectal Adenoma Risk (NCT03663062) | South Tyneside and Sunderland NHS Foundation Trust | 2017-12-27 |
| Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension (NCT03277651) | Shanghai Zhongshan Hospital | 2017-10-09 |
| Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation (NCT04908657) | National Taiwan University Hospital | 2017-07-03 |
| Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography (NCT03342560) | Massachusetts General Hospital | 2017-06-29 |
| Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI (NCT03176797) | Zhujiang Hospital | 2017-05-03 |
| Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01) (NCT03293953) | Ente Ospedaliero Ospedali Galliera | 2017-05-01 |
| Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI (NCT03173287) | University Hospital, Clermont-Ferrand | 2017-03-01 |
| Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging (NCT03637959) | Mayo Clinic | 2017-01-26 |
| A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection (NCT05560503) | Xiangya Hospital of Central South University | 2017-01-01 |
| Mechanism of Serum PRL in the Development of MAFLD (NCT05525884) | Shen Qu | 2017-01-01 |
| FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) (NCT02922751) | Arbor Research Collaborative for Health | 2016-11-16 |
| Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis (NCT03386890) | Beijing Friendship Hospital | 2015-12-01 |
| Biomarkers in the Diagnosis and Prognosis of NAFLD (NCT06098417) | University of Trieste | 2015-09-22 |
| Shear Wave Sonoelastography in Pediatric Liver Fibrosis (NCT02372682) | St. Louis University | 2015-05-11 |
| Development of a Novel Biomarker for Liver Fibrosis (NCT02348814) | University of California, Los Angeles | 2015-05-01 |
| ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B (NCT02313649) | SuperSonic Imagine | 2014-12-01 |
| Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae (NCT02165488) | The University of Hong Kong | 2014-06-01 |
| A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV (NCT02138253) | Conatus Pharmaceuticals Inc. | 2014-05-01 |
| FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis (NCT02476695) | Wuxi Hisky Medical Technology Co Ltd | 2014-05-01 |
| Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy (NCT02041780) | Assistance Publique - Hôpitaux de Paris | 2013-11-01 |
| Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT (NCT01825213) | Massachusetts General Hospital | 2013-11-01 |
| Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa (NCT02060162) | University of Alabama at Birmingham | 2013-10-01 |
| Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases (NCT01988753) | Baylor College of Medicine | 2013-10-01 |
| Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (NCT01934777) | Bambino Gesù Hospital and Research Institute | 2013-10-01 |
| A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial (NCT01965418) | Beijing 302 Hospital | 2013-09-01 |
| Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters (NCT01962155) | Peking University First Hospital | 2013-08-01 |
| Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis (NCT01981421) | Yonsei University | 2013-06-01 |
| Optimized Treatment and Regression of HBV-induced Liver Fibrosis (NCT01938781) | Beijing Friendship Hospital | 2013-06-01 |
| Influence of Probiotics Administration Before Liver Resection in Liver Disease (NCT02021253) | University Hospital, Rouen | 2013-04-01 |
| Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. (NCT01789008) | Rennes University Hospital | 2013-02-01 |
| An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis (NCT02174367) | King's College London | 2012-11-01 |
| Ultrasound Based Acoustic Radiation Force Impulse Imaging (NCT01781208) | University of Michigan | 2012-11-01 |
| Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis (NCT01707472) | Gilead Sciences | 2012-10-04 |
| Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues (NCT01757730) | Arunark Kolipaka | 2012-03-01 |
| Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects (NCT02603666) | Karolinska University Hospital | 2012-01-01 |
| Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C (NCT01537965) | University Hospital, Grenoble | 2012-01-01 |
| Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection (NCT01231685) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-12-01 |
| Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis (NCT01452308) | Gilead Sciences | 2011-11-01 |
| Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection (NCT01341106) | RWTH Aachen University | 2011-04-01 |
| Visceral Stiffness Measurement Using Acoustic Radiation Force Impulse (NCT01311934) | China Medical University Hospital | 2011-03-01 |
| Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome (NCT02353767) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2011-01-01 |
| Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis (NCT01268865) | China Medical University Hospital | 2010-12-01 |
| Improved Prevention of Perinatal Hepatitis B Transmission (NCT01133184) | Hadassah Medical Organization | 2010-09-01 |
| Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV (NCT01935817) | University of Catania | 2010-06-01 |
| Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity (NCT01082419) | University Hospital, Bordeaux | 2010-04-01 |
| Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis (NCT01072721) | Assistance Publique - Hôpitaux de Paris | 2010-01-19 |
| Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis (NCT01260012) | Addis Ababa University | 2010-01-01 |
| Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy (NCT06868394) | Suez Canal University | 2010-01-01 |
| Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) (NCT00896233) | Merck Sharp & Dohme LLC | 2009-08-01 |
| Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients (NCT00926224) | Echosens | 2009-07-01 |
| Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis (NCT01572064) | University of Nottingham | 2009-05-01 |
| A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor (NCT00941902) | Ziv Hospital | 2009-05-01 |
| Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT00885313) | Bambino Gesù Hospital and Research Institute | 2009-03-01 |
| Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure (NCT00777725) | Monash University | 2009-01-01 |